retatrutide type 1 diabetes Eli Lilly and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Flavor:Vanilla Lifestyle:Vegetarian Life Time Group confirms

retatrutide type 1 diabetes Eli Lilly and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C Flavor:Vanilla Lifestyle:Vegetarian Life Time Group confirms

Life Time Group confirms pilot program to include GLP-1 drugs for weight loss

Initially developed to manage type 2 diabetes, these medications help by curbing appetite, slowing digestion, and keeping blood sugar levels in check

Lifestyle:Vegetarian

Flavor:Vanilla

But long before Ozempic and Wegovy became household names, the story of GLP-1s started with early gut-hormone research—and an unlikely breakthrough courtesy of a venomous desert lizard